Company News - Benuvia | Controlled Substance Solutions

Benuvia Operations Announces Strategic Partnership with Cannovation Clinical Research Partners to Deliver Fully Integrated Solutions for Controlled-Substance Therapeutics

Read More
Benuvia Operations Signs Research and Manufacturing Agreement with Leading Ivy League Research University

Read More
Benuvia Sees a Turning Point for Cannabinoid Medicine as Public Awareness Grows

Read More
Advancing Ibogaine Development? You May Be Overlooking a $50M Opportunity

Read More
Shifting Supply Chains Prompt Growing Demand for U.S.-Based CDMO Solutions

Read More
Benuvia Operations Signs Commercial Supply Agreement with Leading U.S. Pharmaceutical Company for Dronabinol API

Read More
Benuvia Operations Signs Research & Development and Manufacturing Agreement with Trait Biosciences to Advance Next-Generation Cannabinoid-Based Products

Read More
Benuvia Operations Awarded NIH Contract for GMP Synthesis of Psilocybin and Other Bulk Drug Substances

Read More
Benuvia Operations Granted GMP Certification from Brazil National Health Surveillance Agency (ANVISA)

Read More
Benuvia Operations, LLC Enters into Licensing Agreement with Avernus Pharma for SYNDROS® CII (dronabinol) in the Gulf Cooperation Council Region

Read More
Benuvia Operations, LLC Enters into Licensing and Supply Agreements with Medra Brasil Medicamentos LTDA

Read More
Benuvia Operations, LLC and Department of Veterans Affairs Sign CRADA Agreement

Read More

Our Company Latest News & Press Releases